Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance.
- NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_assertion description "[Data from the Cancer and Leukemia Group B 8869/8541 study indicate enhanced dose responsiveness to doxorubicin (Adriamycin) in patients who overexpress the HER2 receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance.
- NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_assertion evidence source_evidence_literature NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance.
- NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_assertion SIO_000772 9563896 NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance.
- NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_assertion wasDerivedFrom befree-2016 NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance.
- NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_assertion wasGeneratedBy ECO_0000203 NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance.
- befree-2016 importedOn "2016-02-19" NP1393967.RAwZfV1JGXQKmzkvVRx4TLfYZ1Z7ai5NIed0OHjj9thQA130_provenance.